APA (7th ed.) Citation

O, V. D. M., M, H., V, N., RJ, W., M, M., E, V. B., . . . DR, T. (2018). Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis. The New England journal of medicine, 379(17), 1621. https://doi.org/10.1056/NEJMoa1803484

Chicago Style (17th ed.) Citation

O, Van Der Meeren, et al. "Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis." The New England Journal of Medicine 379, no. 17 (2018): 1621. https://doi.org/10.1056/NEJMoa1803484.

MLA (9th ed.) Citation

O, Van Der Meeren, et al. "Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis." The New England Journal of Medicine, vol. 379, no. 17, 2018, p. 1621, https://doi.org/10.1056/NEJMoa1803484.